Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease-Reference-Cited by-同舟云学术

Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

Published:2016-07 Issue:1 Volume:90 Page:77-89
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Carrillo-López Natalia,Panizo Sara,Alonso-Montes Cristina,Román-García Pablo,Rodríguez Isabel,Martínez-Salgado Carlos,Dusso Adriana S.,Naves Manuel,Cannata-Andía Jorge B.

Publisher

Elsevier BV

Subject

Nephrology

Reference63 articles.

1. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO);Moe;Kidney Int,2006

2. Pathophysiology of vascular calcification in chronic kidney disease;Moe;Circ Res,2004

3. Mechanisms of vascular calcification in chronic kidney disease;Moe;J Am Soc Nephrol,2008

4. Update on Wnt signaling in bone cell biology and bone disease;Monroe;Gene,2012

5. Wnt signaling in osteoblasts and bone diseases;Westendorf;Gene,2004

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystinosis-Associated Metabolic Bone Disease Across Ages and CKD Stages 1 to 5D/T;The Journal of Clinical Endocrinology & Metabolism;2024-07-25

2. Bone-organ axes: bidirectional crosstalk;Military Medical Research;2024-06-12

3. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction;International Journal of Molecular Sciences;2024-05-24

4. N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway;Cell Biochemistry and Biophysics;2024-05-09

5. Non-Classical Effects of FGF23: Molecular and Clinical Features;International Journal of Molecular Sciences;2024-04-30